{Reference Type}: Journal Article
{Title}: Contemporary Treatment Approaches for Human Immunodeficiency Virus Infection: Association of Antiretrovirals with Weight Gain and Potential Solutions.
{Author}: Shroba J;Januszka J;
{Journal}: Nurs Clin North Am
{Volume}: 59
{Issue}: 2
{Year}: 2024 Jun
{Factor}: 1.617
{DOI}: 10.1016/j.cnur.2024.01.004
{Abstract}: Integrase inhibitors and tenofovir alafenamide have become a mainstay in modern antiretroviral therapy; more recently, they have been implicated as causing increased weight gain beyond what may be expected with the "return to health" phenomenon. Some patients, namely those assigned female at birth, of the black race, or with lower baseline CD4 counts, may be more likely to experience weight gain. This review outlines existing evidence linking the agents to excessive weight as well as ongoing efforts to combat these effects.